Whitehawk Therapeutics Inc

WHWK | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.06

+$0.02 (+0.50%)

Sep 22, 2026, 2:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $230.32M

Enterprise Value $40.33M

Beta 0.81

Average Volume 446.03K

Shares Outstanding (Diluted) 82.89M

Shares Change YoY 19.98%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US00032Q1040

Price Performance

Price Change 1M -14.8%

Price Change 3M -7.5%

Price Change 6M 12.5%

Price Change YTD 65.6%

Price Change 1Y 112.6%

Price Change 3Y -19.0%

Price Change 5Y -87.3%

1M CAGR (ann.) -15.1%

1Y CAGR (ann.) 105.1%

5Y CAGR (ann.) -32.1%

All-Time CAGR -28.8%

Valuation

PE Ratio -3.61

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.54

PS Ratio N/A

Forward PS 21.10

PB Ratio 1.26

P/FCF Ratio -3.32

P/Adj. FCF Ratio -2.95

P/OCF Ratio -4.81

EV/Sales N/A

EV/EBIT -0.50

EV/EBITDA -0.50

EV/FCF -0.58

Earnings Yield -27.7%

FCF Yield -30.1%

Adj. FCF Yield -33.9%

Financial Health

Net Cash $189.98M

Total Debt $0

Cash & Short-Term Investments $189.98M

Total Assets $193.99M

Current Ratio 17.38

Quick Ratio 17.38

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 9.39

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -12.7%

Returns

Return on Assets -41.1%

Return on Equity -53.9%

Return on Invested Capital -47.0%

Return on Capital Employed -47.0%

Return on Tangible Assets -41.1%

Historical Growth (CAGR)

Revenue CAGR 3Y -78.7%

Revenue CAGR 5Y -9.1%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 54.2%

EPS CAGR 5Y 52.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y -10.8%

FCF CAGR 5Y -8.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 8.3%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.27

EPS Growth Est (next Q) 3.9%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8

Price Target Upside 98.0%

Cash Flow

Operating Cash Flow $-69.35M

Free Cash Flow $-69.35M

Adj. Free Cash Flow $-78.17M

FCF Per Share -$0.84

OCF Per Share -$0.84

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-5K

Operating Income $-86.06M

EBITDA $-81.29M

Net Income $-79.83M

EPS (Diluted) -$1.12

Revenue / Employee N/A

Profit / Employee $-2.49M

Employees 32